Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sietse M Aukema

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Medical Genetics. Part A|July 4, 2020
A homozygous variant in growth and differentiation factor 2 (GDF2) may cause lymphatic dysplasia with hydrothorax and nonimmune hydrops fetalisSietse M Aukema, Gerdien A Ten Brinke, Wim Timens, et al.
British Journal of Haematology|June 25, 2015
Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrationsSietse M Aukema, Laura Theil, Marius Rohde, et al.
American Journal of Medical Genetics. Part A|December 11, 2021
Tibia hemimelia in a patient with CHARGE syndrome: A rare but recurrent phenomenonSietse M Aukema, Christa M de Geus, Simon G F Robben, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
American Journal of Medical Genetics. Part A|July 17, 2025
Growth Hormone Treatment in Patients With KBG Syndrome: Novel Insights, Challenges and Recommendations From Six New Patients and Literature ReviewSietse M Aukema, Kim Vandenput, Emanuela Scarano, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Genes, Chromosomes & Cancer|July 16, 2015
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphomaRabea Wagener, Sietse M Aukema, Matthias Schlesner, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2021
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic featuresSietse M Aukema, Giorgio A Croci, Susanne Bens, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Blood|October 5, 2018
IG-<i>MYC</i> <sup>+</sup> neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasRabea Wagener, Cristina López, Kortine Kleinheinz, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Medical Genetics. Part A|July 4, 2020
A homozygous variant in growth and differentiation factor 2 (GDF2) may cause lymphatic dysplasia with hydrothorax and nonimmune hydrops fetalisSietse M Aukema, Gerdien A Ten Brinke, Wim Timens, et al.
British Journal of Haematology|June 25, 2015
Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrationsSietse M Aukema, Laura Theil, Marius Rohde, et al.
American Journal of Medical Genetics. Part A|December 11, 2021
Tibia hemimelia in a patient with CHARGE syndrome: A rare but recurrent phenomenonSietse M Aukema, Christa M de Geus, Simon G F Robben, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
American Journal of Medical Genetics. Part A|July 17, 2025
Growth Hormone Treatment in Patients With KBG Syndrome: Novel Insights, Challenges and Recommendations From Six New Patients and Literature ReviewSietse M Aukema, Kim Vandenput, Emanuela Scarano, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Genes, Chromosomes & Cancer|July 16, 2015
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphomaRabea Wagener, Sietse M Aukema, Matthias Schlesner, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2021
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic featuresSietse M Aukema, Giorgio A Croci, Susanne Bens, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Blood|October 5, 2018
IG-<i>MYC</i> <sup>+</sup> neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasRabea Wagener, Cristina López, Kortine Kleinheinz, et al.
Pageof 3